Quick Answer
GENELUX Corp reported Total Revenue of $8.0 thousand for fiscal year 2025.
GENELUX Corp — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $8.0K +0.0% |
$8.0K -95.3% |
$170.0K -98.5% |
$11.07M | — |
| Revenue (ASC 606) | $8.0K +0.0% |
$8.0K -95.3% |
$170.0K -98.5% |
$11.07M | — |
| Net Income | -$32.15M -7.6% |
-$29.87M -5.6% |
-$28.30M -443.4% |
-$5.21M | — |
| Diluted EPS | -$0.86 +9.5% |
-$0.95 +18.1% |
-$1.16 -103.5% |
-$0.57 | — |
| Total Assets | $19.03M -45.2% |
$34.72M +24.5% |
$27.89M +404.3% |
$5.53M | — |
| Cash and Equivalents | $5.33M -37.7% |
$8.56M -9.1% |
$9.42M +2272.3% |
$397.0K | — |
| Stockholders Equity | $11.54M -56.1% |
$26.27M +34.9% |
$19.47M +154.4% |
-$35.78M -8.1% |
-$33.11M |
| R&D Expense | $19.85M +4.5% |
$19.00M +48.8% |
$12.77M +40.6% |
$9.08M | — |
| Operating Income | -$33.21M -4.8% |
-$31.70M -31.2% |
-$24.16M -702.0% |
-$3.01M | — |
| Shares Outstanding | 38.14M +9.8% |
34.73M +29.6% |
26.79M +193.5% |
9.13M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | March 31, 2024 | $8.0K | -95.3% | -95.3% |
| Revenue (ASC 606) | March 31, 2024 | $8.0K | -95.3% | -95.3% |
| Net Income | September 30, 2025 | -$7.95M | -22.9% | -6.6% |
| Diluted EPS | September 30, 2025 | -$0.21 | -10.5% | -5.0% |
| Total Assets | September 30, 2025 | $24.99M | -38.0% | -22.5% |
| Cash and Equivalents | June 30, 2025 | $6.55M | -16.7% | -59.6% |
| Stockholders Equity | September 30, 2025 | $18.59M | -43.8% | -22.2% |
| R&D Expense | September 30, 2025 | $4.74M | +17.0% | -0.4% |
| Operating Income | September 30, 2025 | -$8.19M | -18.1% | -5.2% |
| Shares Outstanding | September 30, 2025 | 38.05M | +10.2% | +0.8% |
- GENELUX Corp reported Total Revenue of $8.0 thousand for fiscal year 2025.
- GENELUX Corp showed an increase of +0.0% in Total Revenue compared to the prior fiscal year.
- GENELUX Corp reported Revenue (ASC 606) of $8.0 thousand for fiscal year 2025.
- GENELUX Corp showed an increase of +0.0% in Revenue (ASC 606) compared to the prior fiscal year.
- GENELUX Corp reported Net Income of -$32.15 million for fiscal year 2025.
- GENELUX Corp showed a decrease of -7.6% in Net Income compared to the prior fiscal year.
- GENELUX Corp reported Diluted EPS of $0.86 per share (loss) for fiscal year 2025.
- GENELUX Corp showed an increase of +9.5% in Diluted EPS compared to the prior fiscal year.
- GENELUX Corp reported Total Assets of $19.03 million for fiscal year 2025.
- GENELUX Corp showed a decrease of -45.2% in Total Assets compared to the prior fiscal year.
- GENELUX Corp reported Cash and Equivalents of $5.33 million for fiscal year 2025.
- GENELUX Corp showed a decrease of -37.7% in Cash and Equivalents compared to the prior fiscal year.
- GENELUX Corp reported Stockholders Equity of $11.54 million for fiscal year 2025.
- GENELUX Corp showed a decrease of -56.1% in Stockholders Equity compared to the prior fiscal year.
- GENELUX Corp reported R&D Expense of $19.85 million for fiscal year 2025.
- GENELUX Corp showed an increase of +4.5% in R&D Expense compared to the prior fiscal year.
- GENELUX Corp reported Operating Income of -$33.21 million for fiscal year 2025.
- GENELUX Corp showed a decrease of -4.8% in Operating Income compared to the prior fiscal year.
- GENELUX Corp reported Shares Outstanding of 38.14 million shares for fiscal year 2025.
- GENELUX Corp showed an increase of +9.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: